Suszek D, Dubaj M, Bigosinski K, Dembowska A, Kaniewski M, Sielwanowska W
Reumatologia. 2024; 62(3):187-195.
PMID: 39055730
PMC: 11267658.
DOI: 10.5114/reum.2024.141291.
Castrejon I, Cano L, Cuadrado M, Borras J, Galindo M, Salman-Monte T
BMC Rheumatol. 2024; 8(1):31.
PMID: 39010239
PMC: 11251319.
DOI: 10.1186/s41927-024-00401-x.
Schultze M, Garal-Pantaler E, Pignot M, Levy R, Carnarius H, Schneider M
BMC Rheumatol. 2024; 8(1):18.
PMID: 38755673
PMC: 11100138.
DOI: 10.1186/s41927-024-00387-6.
Pawar A, Joshi P, Singhai A
J Family Med Prim Care. 2024; 13(3):896-902.
PMID: 38736834
PMC: 11086795.
DOI: 10.4103/jfmpc.jfmpc_1053_23.
Germain G, Worley K, MacKnight S, Rubin B, Bell C, Laliberte F
Lupus Sci Med. 2024; 11(1).
PMID: 38575172
PMC: 11002435.
DOI: 10.1136/lupus-2023-001111.
One-Year Outcomes for Depression and Anxiety in SLE Patients.
Duca L, Roman N, Ifteni P, Teodorescu A
Biomedicines. 2024; 12(3).
PMID: 38540098
PMC: 10968247.
DOI: 10.3390/biomedicines12030484.
Unveiling Ocular Manifestations in Systemic Lupus Erythematosus.
Musa M, Chukwuyem E, Ojo O, Topah E, Spadea L, Salati C
J Clin Med. 2024; 13(4).
PMID: 38398361
PMC: 10889738.
DOI: 10.3390/jcm13041047.
Clinical trial outcomes for SLE: what we have and what we need.
Arnaud L, Parodis I, Devilliers H, Chasset F
Lupus Sci Med. 2024; 11(1).
PMID: 38360028
PMC: 10875561.
DOI: 10.1136/lupus-2023-001114.
Reference Range of Hydroxychloroquine Blood Levels That Can Reduce Odds of Active Lupus and Prevent Flares.
Garg S, Chewning B, Hutson P, Astor B, Bartels C
Arthritis Care Res (Hoboken). 2023; 76(2):241-250.
PMID: 37667434
PMC: 11078155.
DOI: 10.1002/acr.25228.
Serum interferon-alpha predicts in-hospital mortality in patients hospitalised with acute severe lupus.
Yerram K, Baisya R, Kumar P, Mylavarapu R, Rajasekhar L
Lupus Sci Med. 2023; 10(2).
PMID: 37666572
PMC: 10481835.
DOI: 10.1136/lupus-2023-000933.
Epidemiology and Damage Accrual of Systemic Lupus Erythematosus in Central Sweden: A Single-Center Population-Based Cohort Study Over 14 Years From Östergötland County.
Arkema E, Saleh M, Simard J, Sjowall C
ACR Open Rheumatol. 2023; 5(8):426-432.
PMID: 37469135
PMC: 10425583.
DOI: 10.1002/acr2.11585.
Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study.
Hitchon C, Mesa C, Bernstein C, Marrie R, Card C, OBrien S
BMJ Open. 2023; 13(5):e071397.
PMID: 37253487
PMC: 10230332.
DOI: 10.1136/bmjopen-2022-071397.
Aetiologies of Acute Complications in Autoimmune Rheumatologic Diseases: A Hospital-Based Cross-Sectional Study.
P A, Ingle V, Singhai A, Khadanga S, Joshi R, Saigal S
Cureus. 2023; 15(3):e35916.
PMID: 37050995
PMC: 10085520.
DOI: 10.7759/cureus.35916.
Cost Consequence Analysis of Belimumab versus Standard of Care for the Management of Systemic Lupus Erythematosus in Saudi Arabia: A Retrospective Cohort Study.
Alsuwayegh A, Almaghlouth I, Almasaoud M, Alzaid A, Alsuhaibani A, Almana L
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767283
PMC: 9915237.
DOI: 10.3390/ijerph20031917.
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
Nikoloudaki M, Nikolopoulos D, Koutsoviti S, Flouri I, Kapsala N, Repa A
Front Immunol. 2023; 13:1074044.
PMID: 36685524
PMC: 9845912.
DOI: 10.3389/fimmu.2022.1074044.
A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA.
Bell C, Huang S, Yu L, DerSarkissian M, Germain G, Concoff A
Rheumatol Ther. 2022; 10(1):261-274.
PMID: 36471198
PMC: 9931978.
DOI: 10.1007/s40744-022-00509-x.
An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management.
Ameer M, Chaudhry H, Mushtaq J, Khan O, Babar M, Hashim T
Cureus. 2022; 14(10):e30330.
PMID: 36407159
PMC: 9662848.
DOI: 10.7759/cureus.30330.
Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares.
Jorge A, Mancini C, Zhou B, Ho G, Zhang Y, Costenbader K
JAMA. 2022; 328(14):1458-1460.
PMID: 36112387
PMC: 9554698.
DOI: 10.1001/jama.2022.13591.
Characteristics and Obstetric Outcomes in Women With Autoimmune Rheumatic Disease During the COVID-19 Pandemic in Qatar.
Satti E, Ostensen M, Darrgham S, Hadwan N, Ashour H, Al Emadi S
Cureus. 2022; 14(4):e24382.
PMID: 35611042
PMC: 9124580.
DOI: 10.7759/cureus.24382.
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
Bruce I, Furie R, Morand E, Manzi S, Tanaka Y, Kalunian K
Ann Rheum Dis. 2022; 81(7):962-969.
PMID: 35580976
PMC: 9213793.
DOI: 10.1136/annrheumdis-2021-221847.
